AIF Alternative Investment Funds · Abakkus Diversified Alpha Fund  · 1729 Fundamental value Investing 1Y Return: 14.65% · PMS Portfolio Management Services · 1UP MultiManager FOF  · AccuraCap PicoPower Fund  · Gift City Funds  · Ascertis Credit GC Fund IV  · Stakeboat GIFT City Fund I  · Abakkus All Cap Approach  · Abakkus Diversified Alpha Approach  · Abakkus Emerging Opportunities Approach  · ABSL India Flexicap Fund  · ABSL Global Bluechip Equity Fund (IFSC)  · Alpha10  · PicoPower  · Dynamo  · Alphagen  · Ace Multicap  · Ampersand Growth Opportunities Fund – Scheme 1  · A K Securitization & Credit Opportunities Fund II  · Alchemy India Long Term Fund  · Alchemy High Growth  · Leaders of Tomorrow  · Alchemy Select Stock  · ASK Emerging Opportunities Portfolio  · ASK Index Plus Fund  · ASK Indian Entrepreneur Portfolio  · ASK Lighthouse Portfolio  · ASK Absolute Return Fund  · Bharat Bhoomi Fund  · Bharat Value Fund Series IV  · Singularity Fund of Funds AIF  · Buoyant Opportunities PMS  · Carnelian Contra Portfolio Strategy  · Carnelian India Amritkaal Fund  · CCV Emerging Opportunities Fund  · Finavenue Growth Fund  · ICICI Prudential PMS PIPE Strategy  · InCred Credit Opportunities Fund III  · InCred Multicap Portfolio  · Steptrade India Fund  · Neo Special Credit Opportunities Fund II  · Neo Secondaries Fund  · AAA India Equity Fund  · Mavenark Credit and Growth Fund Series 1  · Motilal Oswal Ethical Strategy  · Motilal Oswal Founders Portfolio  · Motilal Oswal Gift City India Equity Fund of Funds Trust  · Motilal Oswal Mid to Mega Strategy  · Neo Income Plus Fund  · Neo Treasury Plus Fund  · Nippon India Equity Opportunities AIF (NIEO)  · Nippon India Equity Opportunities AIF Scheme 11  · Ace Fund  · Aurum Multiplier Portfolio  · Aurum Small Cap Opportunities  · SageOne Core Portfolio  · SageOne Flagship Growth OE Fund  · Steptrade Revolution Fund  · Swyom India Alpha Fund  · Venturex Fund  ·
Premium Access PMS

CARNELIAN CONTRA PORTFOLIO STRATEGY

Distributed through AltPort Experts. Comprehensive fund documentation can be accessed through our research team.
Category PMS
Benchmark BSE 500 TRI
Share: f x in w

About Company

Carnelian Asset Management and Advisors Pvt Ltd

Carnelian Asset Management & Advisors is a boutique investment management firm founded in 2019 by Vikas Khemani, Manoj Bahety and Swati Khemani. The firm operates across portfolio management services, alternative investment funds and offshore investment strategies. As of 31 July 2026, Carnelian reports assets under management of more than ₹19,200 crore across its investment platform. Its investment approach combines fundamental research, disciplined portfolio construction and proprietary forensic analysis to evaluate business quality, governance standards and potential investment risks. The Carnelian Private Growth & Innovation Fund represents the firm’s expansion into private equity through a strategy that combines growth-stage investments, pre-IPO opportunities and listed-market PIPE transactions..

What Is the Carnelian Contra Portfolio Strategy?

The Carnelian Contra Portfolio Strategy PMS is a multi-cap equity portfolio offered by Carnelian Asset Management, designed to seek superior risk-adjusted returns through a contrarian absolute-return approach.

Rather than following market consensus alone, the strategy looks for businesses where temporary problems, cyclical weakness, valuation gaps or corporate events may create an opportunity. The investment universe can include established businesses experiencing short-term dislocation as well as deep-value companies and special situations.

The portfolio typically focuses on around 20 to 25 stocks and carries a 60% large-cap bias. It remains sector-agnostic, allowing the investment team to evaluate opportunities based on business quality, growth prospects, valuation and the specific circumstances affecting each company.

The strategy also uses Carnelian's proprietary forensic analysis process to assess cash flows, liabilities, earnings quality, asset quality and related-party or governance concerns before investment decisions are made.

Carnelian YnG Strategy to Carnelian Contra Portfolio Strategy: What Changed?

The strategy information provided for the current Carnelian Contra Portfolio Strategy does not include a confirmed effective date or detailed terms explaining the transition from Carnelian YnG to the present strategy name. Accordingly, the rename should be understood only as a strategy-history point unless the applicable official documentation confirms the effective date and whether any investment-process or mandate changes accompanied the name change.

Investors reviewing older Carnelian material should therefore distinguish historical references to Carnelian YnG from the current Contra Portfolio Strategy terms.

Carnelian Contra Portfolio Strategy- Key Facts

Parameter Details
Strategy Multi-cap with 60% large-cap bias
Portfolio Size Approximately 20 to 25 stocks
Benchmark BSE 500 TRI
Minimum Investment ₹50 lakh
Exit Load 1% if redeemed within 1 year
Investment Objective Superior risk-adjusted return through a contrarian absolute-return approach
Portfolio Approach Sector-agnostic
Expected 3-year Earnings CAGR Target Approximately 12% to 15%+
ROE Screening Parameter Greater than approximately 15%
Debt-to-Equity Screening Parameter Less than approximately 1.5
Dividend Yield Parameter Approximately 3% to 4%
Portfolio Beta Target Below 1

Source: Latest available Carnelian strategy information provided for this page. Data as of the latest available strategy material. The strategy-specific performance, AUM, risk-ratio and current portfolio allocation figures are not included in the information available here.

Carnelian Contra Portfolio Strategy Investment Philosophy (QGARP)

The Carnelian Contra Portfolio Strategy combines a contrarian mindset with a QGARP, or Quality Growth at a Reasonable Price, orientation.

The objective is not simply to buy companies because they appear inexpensive. The investment framework first examines the quality of the business and its management, then assesses growth potential and valuation. For a contrarian portfolio, this distinction matters because an apparently cheap company can remain cheap if its underlying business quality is deteriorating.

Carnelian's framework broadly evaluates:

  • Quality: Business strength and management credibility.
  • Growth: Potential for accelerated or sustainable earnings growth.
  • Forensic analysis: Financial and governance checks to identify potential red flags.
  • Valuation: Whether the market price is reasonable relative to the company's growth prospects.

Within this framework, Carnelian identifies two broad growth characteristics. A Magic business represents a company where accelerated earnings growth may support valuation re-rating, while a Compounder represents a business with comparatively stable earnings growth.

The strategy therefore combines contrarian opportunities with fundamental discipline rather than treating low valuation as sufficient by itself.

How Does Carnelian Contra Portfolio Strategy Select Stocks?

The strategy's opportunity set is built around situations where market perception, business fundamentals and valuation can temporarily move out of alignment. Four areas are particularly relevant.

1. Structural Growth Stories Facing Temporary Dislocation

The strategy looks for businesses with an underlying structural growth opportunity but temporary factors affecting market sentiment or business performance. The thesis is based on the expectation that the underlying opportunity remains intact while the dislocation may eventually resolve. The timing and extent of recovery remain uncertain, which is why business quality and forensic analysis are important parts of the assessment.

2. Businesses in an Unfavourable Cycle

Cyclical businesses can experience periods of weak demand, compressed margins or unfavourable industry conditions. Carnelian evaluates whether the weakness is temporary and whether the business has the financial and competitive characteristics required to navigate the cycle. The strategy seeks opportunities where the market may be discounting a cyclical downturn more severely than the underlying business warrants.

3. Deep Value Stocks with Healthy Dividends

Another area is deep-value businesses where valuations appear low relative to fundamentals and where dividends can form part of the investment characteristics. The stated framework looks for companies with reasonable business quality, attractive valuation and dividend yields of approximately 3% to 4%. A low valuation alone, however, does not remove the risk of a value trap.

4. Special Situations

The portfolio can also evaluate corporate events that may create temporary valuation gaps. These include demergers, open offers and acquisitions, among other special situations. Such opportunities depend heavily on transaction terms, regulatory developments, execution and market pricing. The outcome can therefore differ materially from the initial investment thesis.

What Is the CLEAR Forensic Framework Used by Carnelian?

Forensic analysis is a central part of Carnelian's investment process. Its proprietary CLEAR framework is designed to examine the financial and governance characteristics of potential investments before capital is committed.

The framework focuses on:

  • Cash Flow Analysis: Examining the relationship between reported profits and actual cash generation.
  • Liability Analysis: Assessing liabilities and financial obligations that may affect the underlying investment case.
  • Earnings Quality Analysis: Looking beyond headline earnings to understand their sustainability and quality.
  • Asset Quality Analysis: Evaluating whether reported assets accurately reflect the business's underlying economic position.
  • Related-Party and Governance Checks: Identifying related-party transactions and governance issues that could affect shareholder value.

This forensic layer complements the broader quality, growth and valuation framework. It is particularly relevant to a contrarian approach because businesses facing temporary problems need to be distinguished from businesses facing structural deterioration.

Carnelian Contra Portfolio Strategy Risk Statistics: Beta, Alpha and Sharpe Ratio

The strategy information provided states a portfolio beta below 1 as a portfolio characteristic. However, current strategy-specific figures for alpha, Sharpe ratio and other risk statistics have not been provided.

Risk Statistic Available Information
Portfolio Beta Target below 1

Source: Latest available Carnelian strategy information provided for this page. Alpha and Sharpe ratio figures should not be inferred from the stated beta or objective.

Carnelian Contra Portfolio Strategy Holdings and Sector Allocation

The strategy is designed as a concentrated portfolio of approximately 20 to 25 stocks, with a 60% large-cap bias and a sector-agnostic mandate.

Portfolio Construction

Portfolio Parameter Stated Approach
Number of Stocks Approximately 20 to 25
Market-Cap Approach Multi-cap
Large-Cap Bias 60%
Sector Approach Sector-agnostic
Benchmark BSE 500 TRI

Source: Latest available Carnelian strategy information provided for this page. Data as of the latest available strategy material.

Sector Allocation

Sector Current Allocation
Sector-wise allocation Not provided in the available strategy information

Source: Latest available Carnelian strategy information provided for this page. Current sector allocation requires the latest portfolio disclosure.

The strategy's sector-agnostic positioning means sector exposure is expected to reflect the opportunities identified through its investment process rather than a predetermined sector allocation.

Carnelian Contra Portfolio Strategy Minimum Investment, Fees and Exit Load

The available terms for the Carnelian Contra Portfolio Strategy minimum investment and exit load are as follows:

  • Minimum investment: ₹50 lakh.
  • Exit load: 1% if the investment is redeemed within one year.
  • Benchmark: BSE 500 TRI.
  • Portfolio structure: Multi-cap with approximately 60% large-cap bias.
  • Portfolio size: Approximately 20 to 25 stocks.

A management fee or performance-linked fee is not specified in the information provided here. Investors should refer to the latest applicable PMS documentation for the current fee structure, including any fixed fee, variable fee, hurdle, taxes, brokerage and other applicable charges.

Key Risks of the Carnelian Contra Portfolio Strategy

1. Market Risk

Equity investments are affected by market movements, economic conditions, interest rates, corporate earnings, investor sentiment and other factors. Portfolio values can fluctuate materially.

2. Contrarian Timing Risk

A contrarian thesis may take longer than expected to play out. The market can continue to disagree with the investment thesis, resulting in an extended period of underperformance.

3. Value Trap Risk

A stock that appears inexpensive may remain cheap because its fundamentals are deteriorating. Temporary dislocation can also become permanent business deterioration.

4. Concentration Risk

A portfolio of approximately 20 to 25 stocks is more concentrated than a broadly diversified equity portfolio. Individual holdings can therefore have a meaningful impact on overall results.

5. Benchmark Divergence Risk

The portfolio may differ substantially from the BSE 500 TRI because of its concentrated, contrarian and sector-agnostic approach. Performance can therefore diverge from the benchmark.

6. Liquidity Risk

Certain securities, particularly during stressed market conditions, may have limited liquidity. This can affect transaction prices and the ability to exit positions efficiently.

7. Fund Manager Risk

Investment outcomes depend partly on the quality of research, portfolio construction, valuation judgments and execution by the portfolio management team. Changes in personnel or investment process can affect the strategy.

Who May Consider the Carnelian Contra Strategy?

The strategy may be relevant to investors who understand the characteristics of discretionary Portfolio Management Services and are comfortable with concentrated equity exposure.

Investors may need to be comfortable with:

  • Equity-market volatility and fluctuations in portfolio value.
  • A concentrated portfolio of approximately 20 to 25 stocks.
  • Contrarian positions that may take time to work.
  • Potential divergence from the BSE 500 TRI.
  • The risks associated with deep-value and special-situation investments.

Investors should also evaluate:

  • Their investment horizon and liquidity requirements.
  • The ₹50 lakh minimum investment requirement.
  • Applicable PMS fees and charges.
  • Their tolerance for periods of relative or absolute underperformance.
  • The latest portfolio, performance and risk disclosures before making an investment decision.

Carnelian Contra vs Carnelian Shift Strategy

Carnelian offers multiple investment structures and strategies, but the available information here does not provide sufficient current, strategy-specific terms for a detailed numerical comparison with Carnelian Shift or Carnelian AIF products.

Parameter Carnelian Contra Portfolio Strategy Other Carnelian Strategies / AIF Options
Structure PMS May vary by product
Investment Approach Contrarian absolute return Strategy-specific
Market-Cap Focus Multi-cap Product-specific
Large-Cap Bias 60% Product-specific
Portfolio Size Approximately 20 to 25 stocks Product-specific
Benchmark BSE 500 TRI Product-specific
Minimum Investment ₹50 lakh Product-specific

The terms of each Carnelian product should be reviewed separately rather than assuming that features of one strategy apply to another.

Carnelian Contra PMS vs Mutual Fund

Parameter Carnelian Contra Portfolio Strategy Mutual Fund
Structure Discretionary PMS Pooled investment vehicle
Portfolio Ownership Securities are held in the client's PMS account, subject to applicable structure and documentation Investors own mutual fund units
Minimum Investment ₹50 lakh Varies by scheme
Portfolio Approach Multi-cap, 60% large-cap bias Depends on scheme mandate
Portfolio Customisation PMS structure may allow greater account-level customisation, subject to mandate and restrictions Generally follows the scheme portfolio
Strategy Contrarian absolute return Depends on scheme
Portfolio Concentration Approximately 20 to 25 stocks Depends on scheme
Benchmark BSE 500 TRI Scheme-specific benchmark
Liquidity Subject to PMS terms and applicable securities Governed by scheme structure and redemption terms

A PMS and mutual fund should not be compared only on historical performance. Investors can review the broader Mutual Fund vs PMS vs AIF comparison to understand differences in ownership, minimum investment, fees, liquidity, taxation and portfolio customisation.

How to Evaluate Carnelian Contra Portfolio Strategy Before Investing

Before evaluating the Carnelian Contra Portfolio Strategy performance or historical returns, investors can review the strategy across several dimensions:

  • Investment philosophy: Understand how the contrarian and QGARP approach is applied.
  • Portfolio construction: Review the current number of holdings, market-cap allocation and concentration.
  • Performance: Examine returns with the relevant period, benchmark and calculation methodology.
  • Risk statistics: Review beta, volatility, drawdowns, alpha and Sharpe ratio where disclosed.
  • Forensic framework: Understand how CLEAR is incorporated into stock selection.
  • Commercial terms: Review the current minimum investment, fees, exit load and applicable expenses.
  • Manager: Assess the experience and continuity of the investment team.
  • Portfolio disclosures: Examine current holdings and sector allocation rather than relying on historical examples.

Investors can also review the key questions to consider when selecting a PMS provider, including registration, investment process, performance reporting, fees, risk controls and team continuity.

How to Invest in Carnelian Contra Portfolio Strategy Through ALTPORT

ALTPORT acts as a distributor and provides information and application support for eligible investors exploring PMS strategies.

Investors interested in the Carnelian Asset Management PMS offering can contact ALTPORT to request the latest strategy information, applicable documentation and onboarding requirements.

 

Disclaimer- Investing in PMS, AIFs, GIFT City products or mutual funds is subject to market risk. Please read the relevant disclosure documents and agreements carefully before investing. Past performance does not guarantee future results, and there is no assurance that the portfolio management strategy will achieve its stated objective. Actual portfolios may differ based on account size, client-imposed restrictions, timing of investment, market conditions, economic factors and individual company developments.

ALTPORT acts as a distributor and information-support platform and does not manage the Carnelian portfolio or guarantee returns or investment outcomes.

Spotify Podcasts
Stream Our Podcasts

Listen to expert conversations and investment insights anytime on Spotify.

Exploring Gift City & Alternate Products: The Future of Investing | AIF & PMS Experts India
Spotify - Podcast
Exploring Gift City & Alternate Products: The Future of Investing | AIF & PMS Experts India
Section: YouTube Podcasts
Watch on YouTube

Watch our podcast episodes featuring expert interviews, market insights, investment strategies, and in-depth discussions on the latest financial trends.

YouTube · Webinar
Is the Market Ready for the Next Big Rally? | Carnelian Asset Management
Section: Performance Analysis
Fund Growth vs Benchmark Trend

Track how the fund has performed against its benchmark over time through a comparative line graph analysis.

CARNELIAN CONTRA PORTFOLIO STRATEGY

Benchmark: BSE 500 TRI

Section: Performance Comparison
Fund vs Benchmark Bar Graph

Compare fund returns and benchmark performance across multiple investment periods using a visual bar graph.

Section: Performance Comparison
Fund vs Benchmark Comparison Table

Review and compare fund returns against benchmark performance across different investment periods in a detailed tabular format.

Carnelian Asset Management & Advisors Pvt Ltd

AUM(Cr.) 1M 3M 6M 1Y 2Y 3Y 4Y 5Y Ince.
Performance ₹138.82 2.00 5.47 4.51 15.12 -1.48 22.92 25.50 NA 24.98
Benchmark NA -0.09 3.86 1.43 4.72 -0.11 12.09 11.90 NA 11.43
Section: Fund Leadership
Meet the Fund Managers

Learn about the experienced fund managers responsible for investment decisions, portfolio strategy, and long-term fund performance.

Swati Khemani

Swati Khemani

Swati Khemani brings 23 years of know-how in the financial world to the table. She’s a great example of today’s Indian woman in business, handling leadership roles, understanding investments, and taking on the challenges of being an entrepreneur.   Her career path is quite diverse. She’s worked in equity research, selling to big institutions, investment banking, and managing people. All this experience gives her a wide view of how the financial industry works.   As one of the people who started Carnelian, she plays a big part in running the business and handling the company’s money. She’s also known for being a mentor and leading with a focus on people, which has helped create a positive work environment at Carnelian. This approach has also been key in building strong relationships with both clients and other businesses.   Swati has always been a supporter of Carnelian’s goals, helping to improve the way the company works, its governance, and its plans for the future. Her career is a story of bouncing back from challenges and striving for success, as she juggles a demanding job with her roles as an entrepreneur and a family leader.

View Profile
Manoj Bahety

Manoj Bahety

Manoj Bahety has worked in financial services for almost 27 years, gaining deep understanding of forensic research and managing investments. Now a fund manager at Carnelian, he puts heavy focus on research when picking stocks for investment. Before starting Carnelian with Vikas Khemani, Manoj had important positions at Edelweiss Securities. These included the Deputy Head of Institutional Equity Research, the Head of Forensic Research, and the Head of Thematic & Mid-Cap Research. At Edelweiss, Manoj developed Analysis Beyond Consensus (ABC Research). This system helps institutional investors make better choices by using solid data instead of just relying on what companies report. Manoj's research has guided investment choices around the world. Outside of his work at Carnelian, Manoj is active with the CFA Institute. He participates in groups like the India Advocacy Committee and the Global Capital Markets Policy Council (CDPC). Manoj’s ability to analyse information and his careful, step-by-step way of doing things are key to how Carnelian operates and makes investment decisions. His past experiences and dedication to thorough research make him a valuable asset in the financial world. In summary, Manoj's extensive background and commitment to data-driven analysis greatly improve Carnelian's investment strategies.

View Profile
Vikas Khemani

Vikas Khemani

Vikas Khemani is the Founder of Carnelian Asset Advisors with over 23 years of experience in the Indian capital markets. Before founding Carnelian, he served as the CEO of Edelweiss Securities Ltd. for 17 years, where he built its institutional equities, investment banking, and equity research businesses into market-leading franchises. He is a triple-qualified investment professional, holding the Chartered Accountant (CA), Chartered Financial Analyst (CFA), and Company Secretary (CS) designations.

View Profile
Get In Touch With
Our Investment Experts

Our experts will understand your goals, map the right strategy across AIFs, PMS, Mutual Funds and Wealth Solutions, and guide you through every step.

Book Your Free 30-Min Call
Section: Help & Support
Frequently Asked Questions

Find answers to common questions about fund investments, performance, portfolio strategy, and investor services.

The Carnelian Contra Portfolio Strategy is a discretionary equity PMS based on a contrarian absolute-return approach. It follows a multi-cap portfolio with a stated 60% large-cap bias and typically focuses on approximately 20 to 25 stocks. The strategy is sector-agnostic and looks for structural growth stories facing temporary dislocation, unfavourable cycles, deep-value opportunities and special situations.

The stated Carnelian Contra Portfolio Strategy minimum investment is ₹50 lakh. Investors should confirm the current minimum investment requirement and applicable documentation before applying because PMS terms can change over time.

The information provided for this page does not specify a confirmed launch date for the current Carnelian Contra Portfolio Strategy. Investors should refer to the latest official strategy documentation for the inception or launch date rather than relying on dates associated with other Carnelian strategies.

The stated benchmark for the Carnelian Contra Portfolio Strategy is the BSE 500 TRI. The benchmark provides a reference point for evaluating portfolio performance, although the strategy's concentrated and contrarian approach can cause its returns to differ materially from the index.

The supplied strategy information identifies Carnelian's senior leadership and investment team, including Vikas Khemani, founder of Carnelian Asset Management & Advisors, and Manoj Bahety, co-founder and fund manager. The current strategy-specific portfolio manager designation should be confirmed from the latest applicable Carnelian documentation.

The strategy information provided for the current Carnelian Contra Portfolio Strategy does not include a confirmed effective date or detailed terms explaining the transition from Carnelian YnG to the present strategy name. Accordingly, the rename should be understood only as a strategy-history point unless the applicable official documentation confirms the effective date and whether any investment-process or mandate changes accompanied the name change. Investors reviewing older Carnelian material should therefore distinguish historical references to Carnelian YnG from the current Contra Portfolio Strategy terms.

The strategy is designed around approximately 20 to 25 stocks. This concentrated structure is consistent with its active, research-led approach and allows the investment team to focus on selected opportunities. Actual client portfolios can differ based on account size, restrictions, timing and other applicable factors.

The information supplied does not specify the current rules governing additional contributions or partial withdrawals. These facilities, along with their minimum amounts, frequency, notice periods and applicable charges, should be confirmed from the current PMS agreement and applicable strategy documentation.

The supplied strategy information does not confirm current NRI eligibility or provide a definitive documentation list. Eligible NRI investors should request the latest onboarding requirements, KYC documents, account details and applicable regulatory documentation through the authorised onboarding channel before proceeding.

No. The Carnelian Contra Portfolio Strategy is market-linked and does not provide guaranteed or assured returns. Its stated objective is to seek superior risk-adjusted returns through a contrarian absolute-return approach. Actual performance can vary because of market conditions, stock selection, valuation changes, portfolio concentration and other factors.

Subscribe to the ALTPORT newsletter

Join HNIs, family offices and NRI investors reading with us.

Please enter a valid email address.

Your details stay confidential and are never shared with third parties.

You're on the list

Thanks — we've added your email to the ALTPORT newsletter.